about
Alpha-lipoic acid for diabetic peripheral neuropathyAldose reductase inhibitors for the treatment of diabetic polyneuropathyAlpha-lipoic acid for diabetic peripheral neuropathySerum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesDiabetic neuropathic pain: Physiopathology and treatmentMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsX-ray crystal structure and small-angle X-ray scattering of sheep liver sorbitol dehydrogenaseDisruption of aldo-keto reductase genes leads to elevated markers of oxidative stress and inositol auxotrophy in Saccharomyces cerevisiaeFunctional studies of aldo-keto reductases in Saccharomyces cerevisiaeRanirestat for the management of diabetic sensorimotor polyneuropathyA potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseasesNutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetesEfficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-AnalysisEfficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy.Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy.Metabolome and proteome changes with aging in Caenorhabditis elegans.Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?Elevated Serum Sorbitol and not Fructose in Type 2 Diabetic Patients.The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.Evaluation of the effects of novel nafimidone derivatives on thermal hypoalgesia in mice with diabetic neuropathy.Post testicular sperm maturational changes in the bull: important role of the epididymosomes and prostasomes.Treatment of painful diabetic neuropathyInvolvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesChronic diabetic complications: the body's adaptive response to hyperglycemia gone awry?Bone marrow-derived TNF-α causes diabetic neuropathy in mice.Inhibitory activities of selected Kampo formulations on human aldose reductaseInactivation of TNF-α ameliorates diabetic neuropathy in mice.Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cellsDiabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammationDirect renin inhibition improves parasympathetic function in diabetesAldose reductase, oxidative stress and diabetic cardiovascular complicationsPathogenesis of diabetic neuropathy: bad to the bone.Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestatNovel transgenic mouse models develop retinal changes associated with early diabetic retinopathy similar to those observed in rats with diabetes mellitus.The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.Ablation of a small subpopulation of diabetes-specific bone marrow-derived cells in mice protects against diabetic neuropathy.Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients.Traditional chinese medicine tang-luo-ning ameliorates sciatic nerve injuries in streptozotocin-induced diabetic rats.Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.Mouse models of diabetic neuropathy.
P2860
Q24187870-8222635F-1A2F-49E4-B162-0BCFC44D32AAQ24242995-D4A03FAF-4957-4B8B-981E-576B62D1228BQ24246065-FF928BB0-5FAF-4DE4-B215-CD0E4ECB11E2Q26747425-CFEE5E1E-0446-431E-BD9D-F64EE9682245Q27004604-A0B461C4-635D-456F-99BC-00A1190D58B4Q27014620-F6DBD276-2F49-4CF7-A4CF-C9057CA65733Q27667716-8B650329-9B07-47FA-9236-9A152BDB79BAQ27934799-270AB3D8-BE42-49C1-90CF-CED912650CC0Q27938824-9051D42A-52D3-43EE-A506-D2DAF13EAA85Q28241270-12ADFC01-CC3E-474F-A67A-B1BFC4F9E488Q28382891-120D0928-7926-4852-BFAC-B7AB17F621E0Q28385506-82FA4568-D4BD-4680-9C82-3F8536C445AAQ28972373-17E0FF7F-9F64-49A0-8C9D-C9FE2B65B9E5Q33574361-684CB54C-D622-4E3D-803F-04FB502A91C4Q33701317-13FC1800-4B94-409D-AF4D-4F32201B9EFBQ33807271-AD6CFDBD-4CED-40A9-9064-C48C90ACF3B1Q33887865-03083343-3008-40BF-9FA4-D47130AE1655Q33887976-E7BF448C-A8B3-4A60-BE1C-8DBD4B634439Q33933972-E04DD8D2-B565-4865-8B02-463F4FF6F389Q33974393-5B0DE212-0A36-4AD9-B813-CA2E164A03EEQ34218896-51524C23-30BD-470E-BC4A-C9B32D7B757BQ34456265-CD24CCFD-64CE-47BA-83E2-3AB2A953179EQ34728267-3C5387CA-935E-43F8-9730-440A60598D28Q34767192-7FC24EF8-599B-4049-8E5F-2536E0B38CFEQ34899309-3F58B4A7-3C32-4BA4-B75B-313732EFC656Q35397913-C7AC983F-0B07-4C96-9253-C70BA40F651AQ35543628-85ECA22D-B7B2-4C97-9357-C869B9FDFAD1Q35993403-4BBE8722-B550-4C05-AE77-AADCEC77EE60Q36082591-2585E63A-8A49-482B-9663-B633928B0E30Q36472703-EF6F6298-E03A-4F10-A7E3-D22BD1FC0C38Q36777049-5BE3EAC9-76B0-4A12-88FD-1979C5C24867Q36796321-94C08B73-569E-4B44-B273-003C2759A0F6Q37035477-38A38897-DD1D-485C-BF7E-ECC411248D2CQ37040313-07023DAE-A89E-4FC3-BBAC-4EF9F3CD7E3DQ37068700-3D98128A-03B7-4919-B34C-EBF418F6C95DQ37148729-B463D3F0-850F-4F0E-A35D-81CD282233D9Q37292061-A47096C4-E721-45A8-BE68-832647D7E4F6Q37316369-4E6BC7CD-20DC-4093-B3BB-7B2EEE431A89Q37409114-EB742C78-4F38-4BEA-BD38-D269E0F7A51EQ37655239-ACAC9B9E-288F-4F99-86DE-C46190D02599
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Polyol pathway and diabetic peripheral neuropathy.
@ast
Polyol pathway and diabetic peripheral neuropathy.
@en
Polyol pathway and diabetic peripheral neuropathy.
@nl
type
label
Polyol pathway and diabetic peripheral neuropathy.
@ast
Polyol pathway and diabetic peripheral neuropathy.
@en
Polyol pathway and diabetic peripheral neuropathy.
@nl
prefLabel
Polyol pathway and diabetic peripheral neuropathy.
@ast
Polyol pathway and diabetic peripheral neuropathy.
@en
Polyol pathway and diabetic peripheral neuropathy.
@nl
P1476
Polyol pathway and diabetic peripheral neuropathy.
@en
P2093
Peter J Oates
P304
P356
10.1016/S0074-7742(02)50082-9
P577
2002-01-01T00:00:00Z